Free Trial
CVE:HEM

Hemostemix (HEM) Stock Price, News & Analysis

Hemostemix logo
C$0.08 +0.01 (+6.67%)
As of 10:26 AM Eastern

About Hemostemix Stock (CVE:HEM)

Key Stats

Today's Range
C$0.08
C$0.08
50-Day Range
C$0.08
C$0.15
52-Week Range
C$0.04
C$0.43
Volume
311,062 shs
Average Volume
387,533 shs
Market Capitalization
C$11.66 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive HEM Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Hemostemix and its competitors with MarketBeat's FREE daily newsletter.

HEM Stock News Headlines

Hemostemix (CVE:HEM) Trading Down 16.7% - Should You Sell?
Hemostemix (CVE:HEM) Stock Price Down 16.7% - Time to Sell?
The Coin That Could Define Trump’s Crypto Presidency
When Trump returned to office, one of his first moves was to tap PayPal’s former COO, David Sacks, as a top advisor on crypto and AI. That alone signaled a shift. But insiders close to D.C. aren’t just talking crypto policy—they’re quietly buying something most retail investors have missed. While the crowd chases Bitcoin to $150,000, Weiss Ratings expert Juan Villaverde believes a different coin—already backed by giants like Google, Visa, and PayPal—could soon become crypto’s “Third Giant.”
Hemostemix (CVE:HEM) Shares Down 16.7% - Should You Sell?
Hemostemix (CVE:HEM) Trading Down 16.7% - Here's What Happened
Hemostemix (CVE:HEM) Shares Down 16.7% - Here's What Happened
Hemostemix (CVE:HEM) Trading Down 16.7% - Here's Why
See More Headlines

HEM Stock Analysis - Frequently Asked Questions

Hemostemix's stock was trading at C$0.12 on January 1st, 2025. Since then, HEM stock has decreased by 37.5% and is now trading at C$0.08.

Shares of HEM stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.

Based on aggregate information from My MarketBeat watchlists, some other companies that Hemostemix investors own include Iplayco (IPC), Capricor Therapeutics (CAPR), Golden Share Resources (GSH), Nuvilex (PMCB), Algernon Pharmaceuticals (AGNPF), Defense Metals (DFMTF) and NIO (NIO).

Industry, Sector and Symbol

Stock Exchange
CVE
Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
Current Symbol
CVE:HEM
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
C($0.03)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-C$5.00 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
37.07%
Return on Assets
-349.24%

Debt

Debt-to-Equity Ratio
-55.07
Current Ratio
0.04
Quick Ratio
0.48

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
C$0.01 per share
Price / Cash Flow
10.77
Book Value
C($0.10) per share
Price / Book
-0.80

Miscellaneous

Outstanding Shares
145,727,000
Free Float
N/A
Market Cap
C$11.66 million
Optionable
Not Optionable
Beta
0.20
7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.

Get This Free Report

This page (CVE:HEM) was last updated on 8/8/2025 by MarketBeat.com Staff
From Our Partners